Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: A previously unreported side effect

Diabetes Care

Volumn 32, Issue 8, 2009, Pages 1428-1430

  Kumaraguru, Janani ^a,b   Flanagan, Sarah E ^a   Greeley, Siri Atma W ^c   Nuboer, Roos ^d   Støy, Julie ^c   Philipson, Louis H ^c   Hattersley, Andrew T ^a,b   Rubio Cabezas, Oscar ^a,e  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CHICAGO   (United States)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^e HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SULFONYLUREA;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; DIARRHEA; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; INFANT; KCNJ 11 GENE; LOW DRUG DOSE; MALE; NEWBORN; NEWBORN DISEASE; PRESCHOOL CHILD; SCHOOL CHILD; TOOTH DISCOLORATION; TREATMENT DURATION;

DENTAL ENAMEL HYPOPLASIA; DIABETES MELLITUS; GLYBURIDE; HUMANS; INFANT, NEWBORN; INSULIN; MUTATION; POTASSIUM CHANNELS, INWARDLY RECTIFYING; TOOTH DISCOLORATION;

EID: 68149141629     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-0280     Document Type: Article

References (8)

1. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njølstad PR, Ashcroft FM, Hattersley AT. Activating mutations in the gene encoding the ATP-sensitive potassium- channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004;350:1838-1849 (erratum in N Engl J Med 2004;351:1470) (Pubitemid 38917250)
2. Støy J, Greeley SA, Paz VP, Ye H, Pastore AN, Skowron KB, Lipton RB, Cogen FR, Bell GI, Philipson LH. United States Neonatal Diabetes Working Group: diagnosis and treatment of neonatal diabetes: a United States experience. Pediatr Diabetes 2008;9:450-459
3. Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Sovik O, Polak M, Hattersley AT. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006;355:467-477 (Pubitemid 44162274)
4. Codner E, Flanagan S, Ellard S, García H, Hattersley AT. High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation. Diabetes Care 2005;28:758-759 (Pubitemid 40315352)
5. Watts A, Addy M. Tooth discolouration and staining: a review of the literature. Br Dent J 2001;190:309-316 (Pubitemid 33755351)
6. Babu KL, Rai K, Hedge AM. Pediatric liquid medicaments: do they erode the teeth surface? An in vitro study: part I. J Clin Pediatr Dent 2008;32:189-194
7. Berggreen E, Heyeraas KJ. Role of K+ATP channels, endothelin A receptors, and effect of angiotensin II on blood flow in oral tissues. J Dent Res 2003;82:33-37
8. Jackson WF. Potassium channels in the peripheral microcirculation. Microcirculation 2005;12:113-127